FORLEX

This brand name is authorized in Turkey

Active ingredients

The drug FORLEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Eformoterol UNII W34SHF8J2K - FORMOTEROL FUMARATE
Formoterol is a predominantly selective β₂-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. Read about Eformoterol
2 Ciclesonide UNII S59502J185 - CICLESONIDE
Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor. Once orally inhaled, ciclesonide is enzymatically converted in the lungs to the principal metabolite (C21-des-methylpropionyl-ciclesonide) which has a pronounced anti-inflammatory activity and is thus considered as the active metabolite. Read about Ciclesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AK	Adrenergics and other drugs for obstructive airway diseases	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants
Discover more medicines within R03AK

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680741520351

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.